title: [Psychopharmacological treatment of patients complicated with cardiovascular disease].
abstract: We've had many opportunities of treating psychiatric problems of patients with cardiovascular diseases(CVD). Several studies have shown the close relationship between psychological factors and CVD. Depression and anxiety increase a prevalence of and worsen a prognosis of CVD. Looking at these patients, we must consider the following: psychotropics-induced hypotension and QT prolongation (antipsychotics and tricyclic antidepressants), cardiovascular drugs induced psychiatric symptoms(diuretics), and cardiac and psychiatric drugs interaction, especially in cytochrome P450 activity(fluvoxamine and paroxetine). Besides a psychopharmacological treatment, psychological approaches based on a therapeutic relationship are important in a cardiac rehabilitation setting.
authors.affiliation: Section of Palliative Care and Psychosomatic Medicine, Oikawa Hospital.
authors.forename: Tetsuaki
authors.initials: T
authors.lastname: Inamitsu
mesh_terms: D001007:Anxiety / Q000188:drug therapy* / Q000209:etiology*; D002318:Cardiovascular Diseases / Q000150:complications*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D011619:Psychotropic Drugs